➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Mallinckrodt
McKesson
Johnson and Johnson
Baxter

Last Updated: May 10, 2021

DrugPatentWatch Database Preview

Clonazepam - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for clonazepam and what is the scope of freedom to operate?

Clonazepam is the generic ingredient in three branded drugs marketed by Alembic Pharms Ltd, Barr, Par Pharm, Sun Pharm Inds Inc, Roche, Accord Hlthcare, Actavis Elizabeth, Mylan, Mylan Pharms Inc, Prinston Inc, Rubicon, Sandoz, Teva, and Watson Labs, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for clonazepam. Thirty-five suppliers are listed for this compound.

Drug Prices for clonazepam

See drug prices for clonazepam

Drug Sales Revenue Trends for clonazepam

See drug sales revenues for clonazepam

Recent Clinical Trials for clonazepam

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Queen Sirikit National Institute of Child HealthN/A
University of CincinnatiPhase 4
Chang Gung Memorial HospitalN/A

See all clonazepam clinical trials

Pharmacology for clonazepam
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for clonazepam

US Patents and Regulatory Information for clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz CLONAZEPAM clonazepam TABLET;ORAL 074925-001 Sep 30, 1997 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Roche KLONOPIN clonazepam TABLET;ORAL 017533-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Get Started for $10   Get Started for $10   Get Started for $10
Par Pharm CLONAZEPAM clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 077171-002 Aug 3, 2005 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-002 Dec 23, 1997 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-003 Dec 23, 1997 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Roche KLONOPIN clonazepam TABLET;ORAL 017533-003 Approved Prior to Jan 1, 1982 AB RX Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Watson Labs CLONAZEPAM clonazepam TABLET;ORAL 074964-003 Dec 30, 1997 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-003 Dec 23, 1997   Get Started for $10   Get Started for $10
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-001 Dec 23, 1997   Get Started for $10   Get Started for $10
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-001 Dec 23, 1997   Get Started for $10   Get Started for $10
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-004 Dec 23, 1997   Get Started for $10   Get Started for $10
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-004 Dec 23, 1997   Get Started for $10   Get Started for $10
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-005 Dec 23, 1997   Get Started for $10   Get Started for $10
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-002 Dec 23, 1997   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Medtronic
Harvard Business School
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.